Article

Patients with pseudoexfoliation syndrome at risk for late PC IOL dislocation

Patients with pseudoexfoliation syndrome (PXF) may be at risk for spontaneous dislocation of posterior chamber (PC) IOLs in the capsular bag that occurs years after the cataract procedure, said Nick Mamalis, MD, professor of ophthalmology, Intermountain Ocular Research Center, John A. Moran Eye Center, University of Utah, Salt Lake City.

Patients with pseudoexfoliation syndrome (PXF) may be at risk for spontaneous dislocation of posterior chamber (PC) IOLs in the capsular bag that occurs years after the cataract procedure, said Nick Mamalis, MD, professor of ophthalmology, Intermountain Ocular Research Center, John A. Moran Eye Center, University of Utah, Salt Lake City.

In a retrospective study of 57 cases of PC IOL dislocation in the capsular bag, 29 patients had PXF, 10 had retinal detachment, and some had undergone pars plana vitrectomy. The IOL dislocation occurred at a mean time of 9 years after implantation (range, 8 to 264 months).

The most common lenses that dislocated were the one-piece, plate haptic silicone lens (14 cases); the one-piece polymethylmethacrylate lens (13 cases); the 3-piece silicone lens (seven cases); and the one-piece hydrophilic lens (seven cases). This problem occurred in all types of lenses, Dr. Mamalis said.

"Patients with PXF are predisposed to this complication and surgeons need to consider ways to prevent this occurrence in these patients, such as the use of capsular tension rings," he said.

PXF syndrome was confirmed with histopathologic analysis, Dr. Mamalis said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.